A carregar...

Efficacy and safety of nivolumab in the treatment of relapsed/refractory classical Hodgkin’s lymphoma: Pavlov First Saint Petersburg State Medical University experience

Background . Using modern first-line chemotherapy more than 80 % of patients with classical Hodgkin’s lymphoma can be cured, however, in 15–20 % of cases there is a relapsed/refractory disease. The use of nivolumab in international clinical practice has significantly improved treatment results of pa...

ver descrição completa

Na minha lista:
Detalhes bibliográficos
Main Authors: K. V. Lepik, N. V. Mikhailova, E. V. Kondakova, L. A. Tsvetkova, Yu. R. Zalyalov, E. S. Borzenkova, I. S. Moiseev, V. V. Baykov, B. A. Afanasyev
Formato: Artigo
Idioma:Russo
Publicado em: ABV-press 2019-01-01
Colecção:Onkogematologiâ
Assuntos:
Acesso em linha:https://oncohematology.abvpress.ru/ongm/article/view/315
Tags: Adicionar Tag
Sem tags, seja o primeiro a adicionar uma tag!